- Adalimumab: Uses, Dosage, Side Effects, Warnings - Drugs. com
Adalimumab works by blocking a protein called tumor necrosis factor (TNF) that can cause inflammation, pain, or other autoimmune symptoms Adalimumab is from a class of medicine called TNF alfa inhibitor Adalimumab first gained FDA approval on December 31, 2002, under the brand name Humira
- Adalimumab - Wikipedia
Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis [43][44][45] It
- Adalimumab (subcutaneous route) - Side effects dosage
Adalimumab injection is used to treat the symptoms and prevent the progression of active rheumatoid arthritis and ankylosing spondylitis It is used in children 2 years of age and older for juvenile idiopathic arthritis
- Adalimumab (Humira) - Uses, Side Effects, and More - WebMD
Overview: Adalimumab is a medicine you inject under the skin It is used for inflammatory or immune problems, such as certain types of arthritis, gut conditions, skin conditions, and an eye
- Adalimumab (Humira®) Drug Information Sheet : Johns Hopkins
What is Adalimumab (Humira®)? Adalimumab is a drug that reduces the signs and symptoms of moderate to severe rheumatoid arthritis (RA), such as joint swelling, pain, and fatigue
- Humira (Adalimumab Injection): Uses Side Effects
ADALIMUMAB (ay da LIM yoo mab) treats autoimmune conditions, such as psoriasis, arthritis, Crohn disease, and ulcerative colitis It works by slowing down an overactive immune system
- adalimumab (Humira): Arthritis Drug Uses, Dosage Side Effects
Adalimumab (Humira) is a drug used for reducing the signs and symptoms of rheumatoid arthritis, psoriatic arthritis, juvenile idopathic arthritis and Crohn's disease
- Adalimumab - StatPearls - NCBI Bookshelf
Adalimumab is a fully human, recombinant monoclonal antibody (mAb) with high affinity, acting as an inhibitor of tumor necrosis factor-alpha (TNF-α) Adalimumab is used to treat various autoimmune conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, Crohn disease, and ulcerative colitis
|